Juan A. Asturias

Tolerability and positive efficacy results after subcutaneous immunotherapy with Parietaria judaica depot extract.

E. Enrique, D. H. de Rojas, Alberto Martínez, 2018, Immunotherapy.

A New Lipid Transfer Protein Homolog Identified as an IgE-Binding Antigen from Japanese Cedar Pollen

A. Díaz‐Perales, T. Aki, G. Salcedo, 2010, Bioscience, biotechnology, and biochemistry.

Development of a hypoallergenic recombinant parvalbumin for first-in-man subcutaneous immunotherapy of fish allergy.

N. Rigby, R. Van Ree, M. Kowalski, 2015, International Archives of Allergy and Immunology.

FAST: towards safe and effective subcutaneous immunotherapy of persistent life-threatening food allergies

N. Rigby, R. Van Ree, C. Mills, 2012, Clinical and Translational Allergy.

Double‐blind, placebo‐controlled Alternaria alternata immunotherapy: in vivo and in vitro parameters

B. García, A. Tabar, J. Algorta, 2007, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

Identification of a polygalacturonase as a major allergen (Pla a 2) from Platanus acerifolia pollen.

M. C. Arilla, I. Ibarrola, Alberto Martínez, 2004, The Journal of allergy and clinical immunology.

Human neutrophils synthesize IL‐8 in an IgE‐mediated activation

R. El Bekay, J. Monteseirín, F. Sobrino, 2004, Journal of leukocyte biology.

Rational Design, Structure–Activity Relationship, and Immunogenicity of Hypoallergenic Pru p 3 Variants

P. Lackner, N. Rigby, P. Briza, 2019, Molecular nutrition & food research.

Genetically engineered hybrid proteins from Parietaria judaica pollen for allergen-specific immunotherapy.

M. C. Arilla, I. Ibarrola, Alberto Martínez, 2007, The Journal of allergy and clinical immunology.